Stivarga | Regorafenib (download only)

Regular price $0.00

 A download link will be emailed after check out.

Stivarga (regorafenib) is indicated for the treatment of patients with metastatic bowel cancer who were previously treated with fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy, anti-VEGF therapy, and if KRAS wild type, an anti-EGFR therapy.